Arcellx, Inc. (ACLX)
NASDAQ: ACLX · IEX Real-Time Price · USD
55.50
-1.38 (-2.43%)
At close: Dec 29, 2023, 4:00 PM
55.49
-0.01 (-0.02%)
After-hours: Dec 29, 2023, 4:13 PM EST
Arcellx Market Cap
Arcellx has a market cap or net worth of $2.70 billion as of December 29, 2023. Its market cap has increased by 98.27% in one year.
Market Cap
2.70B
Enterprise Value
2.37B
1-Year Change
98.27%
Ranking
Category
Stock Price
$55.50
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $2.70B, an increase of 436.89%. That is a compound annual growth rate of 142.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 29, 2023 | 2.70B | -2.43% |
Dec 28, 2023 | 2.77B | -1.23% |
Dec 27, 2023 | 2.80B | -0.69% |
Dec 26, 2023 | 2.82B | 7.69% |
Dec 22, 2023 | 2.62B | 3.80% |
Dec 21, 2023 | 2.53B | 2.41% |
Dec 20, 2023 | 2.47B | -2.77% |
Dec 19, 2023 | 2.54B | 4.74% |
Dec 18, 2023 | 2.42B | -2.70% |
Dec 15, 2023 | 2.49B | -0.35% |
Dec 14, 2023 | 2.50B | 1.54% |
Dec 13, 2023 | 2.46B | 5.14% |
Dec 12, 2023 | 2.34B | -8.23% |
Dec 11, 2023 | 2.55B | -6.86% |
Dec 8, 2023 | 2.74B | -2.88% |
Dec 7, 2023 | 2.82B | 4.17% |
Dec 6, 2023 | 2.71B | 0.49% |
Dec 5, 2023 | 2.69B | 0.20% |
Dec 4, 2023 | 2.69B | 0.38% |
Dec 1, 2023 | 2.68B | 4.66% |
Nov 30, 2023 | 2.56B | 3.63% |
Nov 29, 2023 | 2.47B | -0.80% |
Nov 28, 2023 | 2.49B | -3.96% |
Nov 27, 2023 | 2.59B | -0.13% |
Nov 24, 2023 | 2.59B | -0.19% |
View and export this data all the way back to 2022.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Intellia Therapeutics | 2.73B |
GoodRx Holdings | 2.72B |
Privia Health Group | 2.72B |
Rhythm Pharmaceuticals | 2.72B |
Rocket Pharmaceuticals | 2.70B |
Zai Lab | 2.69B |
Galapagos NV | 2.68B |
CymaBay Therapeutics | 2.68B |